PATENT CLAIM ANALYSIS

Application Number: 15990313
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "450000"]

Abstract:
Compositions which comprise a liposomal camptothecin and optionally liposomal fluoropyrimidine and a targeted antitumor agent are useful in achieving enhanced therapeutic effects when combinations of these agents are administered.

Claim (Index 5):
The method of  claim 1 , wherein said first liposomes further comprise a fluoropyrimidine, wherein the mol ratio of said camptothecin to said fluoropyrimidine is non-antagonistic, and said camptothecin and fluoropyrimidine are stably associated with said first liposomes.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.15385
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['09807332', '14352662', '15891170', '10417631', '14990167']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7564214643130693
- 35 USC 102 Novelty (BERT): 0.4899194893660458
- Combined Prediction Score: 0.7297712668183669
- Mean Citation Score: 213.047808
- Max Citation Score: 223.26814
- Similarity Product: 169.13508961960198

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test